In the tumors harvested from the tamoxifen-induced MCT2 KO, we found that their mitochondria were disrupted compared to CO tumors, suggesting that these alterations in MCT2 expression may impose adverse effects on the tumor cell bioenergetics and promote the emergence of more aggressive cancer. The gene discussed is SLC16A7; the disease is cancer.